Herbalife (HLF) Q4 2025 earnings review

Growth Accelerates, Leverage Target Beaten

Herbalife closed FY25 with strong momentum, delivering 6.3% YoY revenue growth in Q4 (exceeding guidance) and beating Adjusted EBITDA targets. The turnaround story is taking shape with sustained growth in Latin America (+17.6%) and EMEA (+9.2%), though North America slipped back into negative territory (-0.8%). Financial discipline remains a highlight: the company reduced its leverage ratio to 2.8x, achieving its sub-3.0x goal ahead of schedule. FY26 guidance forecasts continued acceleration with Q1 sales expected up 3-7%.

๐Ÿ‚ Bull Case

International Strength

Latin America is surging (+17.6% YoY) and EMEA remains robust (+9.2% YoY). These regions are successfully offsetting weakness in China and North America.

Balance Sheet Repair

Total leverage ratio dropped to 2.8x, surpassing the company's 3.0x target. FY25 Operating Cash Flow was solid at $333M, providing flexibility for future investments like Pro2col.

๐Ÿป Bear Case

North America Stalls

After finally returning to growth in Q3 (+1%), North America relapsed to -0.8% YoY in Q4. As a mature primary market, this volatility raises questions about the durability of the turnaround.

China Continues to Drag

China net sales fell 4.4% YoY (5.6% on a constant currency basis). The region remains a persistent headwind with no immediate signs of a pivot to growth.

โš–๏ธ Verdict: ๐ŸŸข

Bullish. The acceleration in top-line growth to +6.3% and the early achievement of leverage targets suggests the turnaround strategy is working. While North America's slight dip is a blemish, the strong Q1 2026 guidance implies management sees the momentum continuing.

Key Themes

DRIVER๐ŸŸข๐ŸŸข

Latin America Driving Growth

Latin America has become the engine of Herbalife's recovery, delivering its seventh straight quarter of growth. Q4 sales jumped 17.6% reported (11.0% constant currency). This consistency contrasts sharply with the volatility in developed markets.

DRIVERNEW๐ŸŸข

Pro2col Ecosystem & Ronaldo Investment

The digital transformation narrative intensified with Cristiano Ronaldo investing $7.5M for a stake in the Pro2col software subsidiary. Beta 2.0 was released in Q4 to distributors in North America. This moves the initiative from 'concept' to 'commercial asset,' with potential SaaS revenue streams ($25M SaaS implementation costs capitalized in FY25).

CONCERNโšช

North America Reversal

Reversing. After breaking a multi-year decline in Q3 2025 with +1.0% growth, North America slipped back to -0.8% in Q4. While new distributor numbers in NA are up 19%, this has not yet translated into sustained revenue conversion, suggesting a lag or productivity issue with new entrants.

CONCERNโšช

Gross Margin Compression

Gross profit margin fell 30 bps YoY to 77.5%. The primary drivers were FX headwinds (100 bps) and input cost inflation (30 bps), which outweighed pricing benefits (80 bps). While not a collapse, it indicates that pricing power is currently insufficient to fully offset macro headwinds.

CONCERN๐Ÿ”ด

Global Recruitment Softness

Despite the North American surge in new distributors, worldwide new distributors declined 5% YoY in Q4. Management cites a 16% increase on a two-year stack, but the YoY drop suggests the recruiting momentum is not uniform globally.

Other KPIs

Adjusted EBITDA (25Q4)$156.1 million

Exceeded guidance. Represents a 12.2% margin (down 20 bps YoY). Full-year EBITDA margin expanded 40 bps to 13.1%, showing operational leverage despite the Q4 FX pressure.

Net Cash from Operations (FY25)$333.3 million

Strong generation (+16.8% vs FY24's $285.4M). This cash flow enabled the company to handle capital expenditures ($80.4M) and reduce debt, ending with $353M in cash on hand.

Total Leverage Ratio2.8x

Improved from 3.2x at the start of the year. The company successfully executed its deleveraging plan, beating the 3.0x target. Revolver is undrawn as of year-end.

Guidance

26Q1 Net Sales Growth+3.0% to +7.0%

Accelerating. The midpoint (5.0%) suggests a slight deceleration from Q4's 6.3% reported, but implies continued momentum compared to the negative growth seen in early 2025. Constant currency guide is +0.5% to +4.5%.

FY26 Net Sales Growth+1.0% to +6.0%

Stable/Accelerating. The range midpoint (3.5%) is significantly higher than the FY25 actual growth of 0.9%, signaling confidence in the turnaround taking hold for the full year.

FY26 Adjusted EBITDA$670 - $710 million

Accelerating. At the midpoint ($690M), this represents ~5% growth over FY25's $657.6M. This outlook implies margin stability or slight expansion despite continued FX volatility.

FY26 CapEx$50 - $80 million

Stable. Consistent with FY25 actuals of $80.4M, indicating no massive capital outlay spikes are required to support the new digital initiatives (aside from capitalized SaaS costs).

Key Questions

North America Volatility

North America improved to +1% in Q3 but fell back to -0.8% in Q4 despite +19% new distributor growth. What is causing the conversion lag, and does the Q1 guidance assume NA returns to positive territory?

Pro2col Monetization

With the Ronaldo investment and Beta 2.0 release, when will Pro2col contribute materially to revenue? Are the capitalized SaaS costs ($25M in FY25) expected to rise in FY26?

China Strategy

China remains a drag (-4.4% reported). Is the strategic transition in this region complete, and what specific leading indicators suggest a bottom is near?